Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 10 | 2021 | 352 | 1.550 |
Why?
|
| Artificial Intelligence | 2 | 2020 | 135 | 1.360 |
Why?
|
| Natural Language Processing | 5 | 2021 | 68 | 1.350 |
Why?
|
| Emergency Service, Hospital | 4 | 2019 | 658 | 1.110 |
Why?
|
| Health Information Exchange | 3 | 2016 | 37 | 0.910 |
Why?
|
| Patient Portals | 1 | 2021 | 12 | 0.890 |
Why?
|
| Biological Ontologies | 1 | 2019 | 4 | 0.820 |
Why?
|
| Telemedicine | 4 | 2020 | 646 | 0.800 |
Why?
|
| Medical Informatics Applications | 2 | 2019 | 22 | 0.800 |
Why?
|
| Microbiota | 2 | 2021 | 70 | 0.800 |
Why?
|
| Data Anonymization | 1 | 2019 | 9 | 0.790 |
Why?
|
| Information Dissemination | 3 | 2021 | 109 | 0.780 |
Why?
|
| Medical Overuse | 2 | 2016 | 27 | 0.780 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 67 | 0.780 |
Why?
|
| Medical Record Linkage | 2 | 2016 | 41 | 0.770 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 85 | 0.720 |
Why?
|
| Prostatic Neoplasms | 2 | 2021 | 760 | 0.670 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 139 | 0.660 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 150 | 0.660 |
Why?
|
| Mental Disorders | 2 | 2019 | 625 | 0.620 |
Why?
|
| Ethics Committees, Research | 1 | 2016 | 22 | 0.610 |
Why?
|
| Informed Consent | 5 | 2019 | 127 | 0.550 |
Why?
|
| Databases, Factual | 3 | 2021 | 597 | 0.530 |
Why?
|
| International Classification of Diseases | 3 | 2019 | 84 | 0.510 |
Why?
|
| Database Management Systems | 1 | 2012 | 25 | 0.490 |
Why?
|
| Models, Theoretical | 1 | 2016 | 381 | 0.480 |
Why?
|
| Algorithms | 6 | 2020 | 1159 | 0.480 |
Why?
|
| Clinical Trials as Topic | 4 | 2020 | 843 | 0.480 |
Why?
|
| Computational Biology | 1 | 2012 | 178 | 0.430 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 712 | 0.430 |
Why?
|
| Forecasting | 1 | 2021 | 267 | 0.400 |
Why?
|
| South Carolina | 7 | 2020 | 2636 | 0.400 |
Why?
|
| Biological Specimen Banks | 3 | 2021 | 34 | 0.390 |
Why?
|
| Machine Learning | 3 | 2021 | 155 | 0.370 |
Why?
|
| Humans | 38 | 2021 | 68792 | 0.350 |
Why?
|
| Pandemics | 4 | 2021 | 309 | 0.330 |
Why?
|
| Adrenal Hyperplasia, Congenital | 5 | 2007 | 23 | 0.320 |
Why?
|
| Models, Biological | 1 | 2021 | 958 | 0.320 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1779 | 0.290 |
Why?
|
| Hospitalization | 1 | 2021 | 895 | 0.290 |
Why?
|
| Hydroxysteroid Dehydrogenases | 3 | 1994 | 6 | 0.290 |
Why?
|
| Decision Support Techniques | 4 | 1999 | 3221 | 0.280 |
Why?
|
| Biopsy | 3 | 1999 | 3573 | 0.280 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 233 | 0.280 |
Why?
|
| Data Warehousing | 2 | 2021 | 21 | 0.280 |
Why?
|
| Information Management | 2 | 2013 | 23 | 0.260 |
Why?
|
| Clinical Competence | 3 | 1999 | 3653 | 0.260 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 4741 | 0.230 |
Why?
|
| Male | 17 | 2021 | 36233 | 0.220 |
Why?
|
| Biomedical Research | 2 | 2017 | 298 | 0.220 |
Why?
|
| Privacy | 1 | 2021 | 5 | 0.220 |
Why?
|
| Cloud Computing | 1 | 2021 | 4 | 0.220 |
Why?
|
| Breast Neoplasms | 3 | 1999 | 4510 | 0.220 |
Why?
|
| Prostatectomy | 1 | 2021 | 85 | 0.210 |
Why?
|
| Organizational Case Studies | 1 | 2020 | 50 | 0.210 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 58 | 0.210 |
Why?
|
| Adult | 11 | 2021 | 20717 | 0.200 |
Why?
|
| Case-Control Studies | 4 | 2019 | 1488 | 0.200 |
Why?
|
| Acute Coronary Syndrome | 1 | 2021 | 187 | 0.200 |
Why?
|
| Medical Informatics | 1 | 2020 | 66 | 0.200 |
Why?
|
| Tobacco Use | 1 | 2020 | 81 | 0.200 |
Why?
|
| Confidentiality | 1 | 2019 | 55 | 0.190 |
Why?
|
| ROC Curve | 1 | 2020 | 371 | 0.190 |
Why?
|
| Support Vector Machine | 1 | 2019 | 12 | 0.190 |
Why?
|
| Female | 18 | 2021 | 39962 | 0.190 |
Why?
|
| Narration | 1 | 2019 | 24 | 0.190 |
Why?
|
| Patient Selection | 2 | 2013 | 579 | 0.190 |
Why?
|
| Social Isolation | 1 | 2019 | 40 | 0.190 |
Why?
|
| Phenotype | 2 | 2021 | 917 | 0.190 |
Why?
|
| Betacoronavirus | 1 | 2020 | 113 | 0.190 |
Why?
|
| Brain Infarction | 1 | 2019 | 53 | 0.180 |
Why?
|
| Software | 3 | 2016 | 403 | 0.180 |
Why?
|
| Unified Medical Language System | 1 | 2017 | 6 | 0.170 |
Why?
|
| User-Computer Interface | 4 | 2013 | 227 | 0.170 |
Why?
|
| Datasets as Topic | 1 | 2017 | 50 | 0.170 |
Why?
|
| African Americans | 2 | 2021 | 1898 | 0.170 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 390 | 0.170 |
Why?
|
| Risk Assessment | 2 | 2021 | 1934 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 232 | 0.160 |
Why?
|
| Patient Identification Systems | 1 | 2016 | 20 | 0.160 |
Why?
|
| Documentation | 2 | 2013 | 81 | 0.150 |
Why?
|
| Bayes Theorem | 1 | 2017 | 276 | 0.150 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 191 | 0.150 |
Why?
|
| Workflow | 1 | 2016 | 97 | 0.150 |
Why?
|
| Population Surveillance | 1 | 2016 | 280 | 0.130 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 2727 | 0.130 |
Why?
|
| Age Factors | 2 | 2016 | 1808 | 0.130 |
Why?
|
| Intention | 1 | 2014 | 76 | 0.130 |
Why?
|
| Patient Simulation | 1 | 1994 | 61 | 0.130 |
Why?
|
| Social Support | 1 | 2016 | 409 | 0.130 |
Why?
|
| Videotape Recording | 1 | 2013 | 43 | 0.130 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1994 | 206 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 274 | 0.130 |
Why?
|
| Research Subjects | 1 | 2013 | 45 | 0.120 |
Why?
|
| Computers, Handheld | 1 | 2013 | 41 | 0.120 |
Why?
|
| Pregnancy | 3 | 2016 | 2231 | 0.120 |
Why?
|
| Patient Preference | 1 | 2013 | 54 | 0.120 |
Why?
|
| Tissue Donors | 1 | 2014 | 189 | 0.120 |
Why?
|
| Lysine | 1 | 1992 | 95 | 0.120 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2013 | 123 | 0.120 |
Why?
|
| Tyrosine | 1 | 1992 | 192 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 505 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2014 | 751 | 0.110 |
Why?
|
| Costs and Cost Analysis | 3 | 1999 | 3217 | 0.110 |
Why?
|
| Lymphatic Metastasis | 3 | 1999 | 3305 | 0.110 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 185 | 0.100 |
Why?
|
| Prenatal Diagnosis | 2 | 2001 | 69 | 0.100 |
Why?
|
| Computer Simulation | 1 | 1994 | 674 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2021 | 611 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 117 | 0.100 |
Why?
|
| Young Adult | 4 | 2021 | 5496 | 0.100 |
Why?
|
| Neoplasm Staging | 3 | 1999 | 3822 | 0.100 |
Why?
|
| Survival Rate | 3 | 1999 | 4060 | 0.100 |
Why?
|
| Steroid 21-Hydroxylase | 2 | 2007 | 13 | 0.100 |
Why?
|
| Middle Aged | 7 | 2021 | 20597 | 0.100 |
Why?
|
| Aged | 5 | 2021 | 14503 | 0.090 |
Why?
|
| Dexamethasone | 3 | 2004 | 145 | 0.090 |
Why?
|
| Research Personnel | 2 | 2019 | 80 | 0.080 |
Why?
|
| Comorbidity | 1 | 2021 | 1386 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1035 | 0.080 |
Why?
|
| Child Development | 2 | 2004 | 97 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2016 | 1290 | 0.080 |
Why?
|
| Computer Communication Networks | 2 | 1996 | 28 | 0.070 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 3 | 1994 | 5 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 2004 | 222 | 0.070 |
Why?
|
| Mutation | 3 | 2007 | 1184 | 0.070 |
Why?
|
| Play and Playthings | 1 | 2004 | 23 | 0.070 |
Why?
|
| Gender Identity | 1 | 2004 | 47 | 0.070 |
Why?
|
| Child Behavior | 1 | 2004 | 55 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2021 | 6845 | 0.070 |
Why?
|
| CHO Cells | 2 | 1993 | 157 | 0.060 |
Why?
|
| Cricetinae | 2 | 1993 | 260 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2004 | 146 | 0.060 |
Why?
|
| Interpersonal Relations | 1 | 2004 | 207 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 1994 | 1436 | 0.060 |
Why?
|
| Research Design | 2 | 2019 | 711 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2004 | 277 | 0.060 |
Why?
|
| Acceleration | 1 | 2021 | 36 | 0.060 |
Why?
|
| Systems Integration | 1 | 2021 | 31 | 0.060 |
Why?
|
| Adolescent | 5 | 2017 | 8641 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4729 | 0.060 |
Why?
|
| Base Sequence | 2 | 1993 | 1001 | 0.050 |
Why?
|
| Risk Factors | 1 | 2021 | 5494 | 0.050 |
Why?
|
| Motor Activity | 1 | 2004 | 603 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2016 | 3095 | 0.050 |
Why?
|
| Endocrinology | 1 | 1999 | 15 | 0.050 |
Why?
|
| Cognition | 1 | 2004 | 479 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2021 | 614 | 0.050 |
Why?
|
| Personal Narratives as Topic | 1 | 2019 | 4 | 0.050 |
Why?
|
| Decision Trees | 1 | 2019 | 75 | 0.050 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 168 | 0.050 |
Why?
|
| United States | 1 | 2021 | 7025 | 0.050 |
Why?
|
| Random Allocation | 1 | 2019 | 426 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 1999 | 277 | 0.040 |
Why?
|
| Infant | 3 | 2016 | 2791 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2020 | 321 | 0.040 |
Why?
|
| Clinical Coding | 1 | 2016 | 21 | 0.040 |
Why?
|
| Directories as Topic | 1 | 1996 | 4 | 0.040 |
Why?
|
| Child | 4 | 2016 | 6070 | 0.040 |
Why?
|
| Pediatrics | 1 | 1999 | 349 | 0.040 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 92 | 0.040 |
Why?
|
| Cost Savings | 1 | 2016 | 106 | 0.040 |
Why?
|
| Data Display | 1 | 1995 | 17 | 0.040 |
Why?
|
| Genetic Research | 1 | 2014 | 16 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 813 | 0.030 |
Why?
|
| Trust | 1 | 2014 | 70 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1994 | 1076 | 0.030 |
Why?
|
| Paper | 1 | 2013 | 24 | 0.030 |
Why?
|
| Cortisone | 1 | 1993 | 4 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 1996 | 369 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2016 | 311 | 0.030 |
Why?
|
| Introns | 1 | 1993 | 68 | 0.030 |
Why?
|
| Genes | 1 | 1993 | 80 | 0.030 |
Why?
|
| Comprehension | 1 | 2013 | 65 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 28 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1992 | 81 | 0.030 |
Why?
|
| Health Literacy | 1 | 2013 | 57 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 440 | 0.030 |
Why?
|
| Minority Groups | 1 | 2014 | 183 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 427 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2016 | 390 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1993 | 374 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 1993 | 279 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2242 | 0.030 |
Why?
|
| Time Factors | 2 | 2004 | 4527 | 0.030 |
Why?
|
| Hospitals | 1 | 2013 | 238 | 0.030 |
Why?
|
| Kinetics | 1 | 1992 | 1032 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1993 | 535 | 0.030 |
Why?
|
| Transfection | 1 | 1992 | 769 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 732 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1993 | 468 | 0.030 |
Why?
|
| Motivation | 1 | 2014 | 541 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2134 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 1995 | 763 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1993 | 1601 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 2106 | 0.020 |
Why?
|
| Animals | 3 | 1994 | 20109 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2004 | 2363 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 740 | 0.020 |
Why?
|
| Rats | 1 | 1992 | 5070 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2004 | 89 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 1586 | 0.020 |
Why?
|
| Chorionic Villi Sampling | 1 | 2001 | 8 | 0.010 |
Why?
|
| Virilism | 1 | 2001 | 5 | 0.010 |
Why?
|
| Amniocentesis | 1 | 2001 | 13 | 0.010 |
Why?
|
| Homozygote | 1 | 2001 | 104 | 0.010 |
Why?
|
| Health Surveys | 1 | 2004 | 487 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2001 | 194 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 170 | 0.010 |
Why?
|
| Prenatal Care | 1 | 2001 | 108 | 0.010 |
Why?
|
| Gonadal Disorders | 1 | 1999 | 2 | 0.010 |
Why?
|
| Adrenal Gland Diseases | 1 | 1999 | 5 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1999 | 22 | 0.010 |
Why?
|
| New York | 1 | 1999 | 217 | 0.010 |
Why?
|
| Thyroid Diseases | 1 | 1999 | 33 | 0.010 |
Why?
|
| Adrenal Cortex | 1 | 1999 | 9 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 1999 | 94 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1999 | 60 | 0.010 |
Why?
|
| Steroids | 1 | 1999 | 78 | 0.010 |
Why?
|
| Boston | 1 | 1996 | 32 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 1996 | 43 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 1996 | 68 | 0.010 |
Why?
|
| Software Design | 1 | 1995 | 19 | 0.010 |
Why?
|
| Information Systems | 1 | 1995 | 44 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 1520 | 0.010 |
Why?
|
| Mineralocorticoids | 1 | 1994 | 8 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1994 | 18 | 0.010 |
Why?
|